25-hydroxyvitamin D levels, race, and the progression of kidney disease. - sprookjes - yvandenbroek - TriplyDB

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

http://www.wikidata.org/entity/Q37477768

about

Genetic variation in APOL1 associates with younger age at hemodialysis initiation Vitamin D and cardiovascular disease: potential role in health disparities Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease Physical performance and frailty in chronic kidney disease Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.Vitamin D insufficiency.Vitamin D deficiency and non-lipid biomarkers of cardiovascular risk.25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases.Serum 25-hydroxyvitamin D concentration is associated with functional capacity in older adults with heart failure.Mortality rates across 25-hydroxyvitamin D (25[OH]D) levels among adults with and without estimated glomerular filtration rate <60 ml/min/1.73 m2: the third national health and nutrition examination survey.Oral supplementation with cholecalciferol 800 IU ameliorates albuminuria in Chinese type 2 diabetic patients with nephropathy Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.Low serum calcium is associated with poor renal outcomes in chronic kidney disease stages 3-4 patients.Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population.Renal function can improve at any stage of chronic kidney disease.The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot study Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease Vitamin D and racial disparity in albuminuria: NHANES 2001-2006 Role of vitamin D receptor activation in racial disparities in kidney disease outcomes.Racial disparity in blood pressure: is vitamin D a factor?Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006.Vitamin D therapy in chronic kidney disease and end stage renal disease.25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files.Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate Vitamin D supplementation in pre-dialysis chronic kidney disease: A systematic review.Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.Biomarkers of Vitamin D Status and Risk of ESRD Variation in vitamin D supplementation among adults in a multi-race/ethnic health plan population, 2008.Vitamin D status and outcomes after renal transplantation.Significant independent predictors of vitamin d deficiency in inpatients and outpatients of a nephrology unit.Predictors of serum vitamin D levels in African American and European American men in Chicago Vitamin D in chronic kidney disease Cardiometabolic risk factors related to vitamin d and adiponectin in obese children and adolescents Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users.Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients Differences in progression to ESRD between black and white patients receiving predialysis care in a universal health care system.

P2860

Q24632005-20015428-D1D3-44A4-86BB-653555DE0163 Q26991916-C07A240F-EE5B-46A3-812C-27ADB6FA25AC Q27022366-0147CE7A-8C82-453B-91EA-6545DE0901DB Q33604462-0026FF78-7AA2-49EC-AE56-74725FD6AA64 Q33622180-180935B5-00A8-45CD-B954-251DB93B75BB Q33782547-289FC011-B383-4C1C-9AD4-A9D84CFFB492 Q33904409-CB8516D2-2911-478B-B87D-C917EAEC5054 Q34324553-71455E41-9BD4-41C8-BD5C-69939503D5C6 Q34346370-408923A6-EDD5-4D31-AB4C-B4BB6876722F Q34385578-E56283A1-8FC3-4742-9DF6-968C20AA6394 Q34462171-264C11A6-486B-4BFA-803C-A381B5A22106 Q34500399-D16A7C4B-C9FB-43D1-B23C-B1BAB4BBEE2B Q34604473-C95766B1-D6F0-4FB6-97C8-A06D793E29D0 Q34629938-1BE36D79-986F-4AC6-8AFD-DED888EFC157 Q34650709-78B30EDD-A2D5-47DB-B1F1-B00E2DC373C2 Q35003466-4A4B757C-FD8C-4EE0-8597-C8DBDFB43CA0 Q35069799-A52B2178-767B-40C7-9A8E-52612AB89F97 Q35131450-D006CE89-97BB-400F-8E7A-48544CFE0145 Q35210184-5B8E67B7-FE77-4FFF-9FE0-49FE32CBC1B4 Q35222833-06CA9C0B-0A1B-4304-BE24-19F150DC39C5 Q35229936-8B46BE7B-DFDF-401C-80BE-52D75A31238D Q35235556-622A2595-7BF7-4E79-8AD9-51EF50B5F77A Q35597904-F6892A07-3257-41F8-A3D8-78F1D8323BDE Q35758581-8207F7B3-EC1B-4E81-89F7-5901145B59E0 Q35830979-09305ABA-22D6-40BA-855D-CC0B1E8604B4 Q35983519-9C718F16-F953-4B2C-8841-93EE832186D4 Q36187587-3F0BC22D-5A7B-44EC-812C-5C6947A6E2C6 Q36214884-BDF5656A-178A-45F7-BF84-DD7C46CDA4F0 Q36227387-95A3E1A3-F862-439C-A892-E987935F5B74 Q36349451-1ACB62E0-B1E9-4150-9798-1FC50F276289 Q36494759-18BFC638-3AAF-4875-BBEC-7AA0E807D50D Q36597123-922A6B17-07DA-4594-A7B5-D646010B6ACE Q36796584-FA2AD0CA-C0B4-42DA-B868-B5F3A6021E57 Q36869308-DD60D575-4CE8-4677-9794-468DD16E8DFE Q36919008-C13320F5-00B9-4356-BC93-3064101BB46E Q36956587-8D334222-C13A-425E-8897-A2A0749F5925 Q37091052-58B890D7-7273-45CB-8A19-B355650C8439 Q37155210-4592E03E-1206-4618-BE5A-B1D3016160EB Q37243054-B4F37787-A714-40A6-AB86-3834EFA8DB3C Q37246989-7B870C13-FEB0-4589-B304-7B0352C2ACD5

P2860

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

http://www.wikidata.org/entity/Q37477768

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

@en

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

@nl

type

label

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

@en

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

@nl

prefLabel

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

@en

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

@nl

P1433

Q37477768-AC6416FE-FCCB-49B0-A7AE-DE674E03DABB

P1476

Q37477768-D1D2CC80-BB9A-4370-AE5B-724972E13246

P2093

Q37477768-318A948F-E4E7-419E-AB72-ACE030FDC205

Q37477768-4BD6B8F9-4FF9-459B-B426-EC08FE523BBC

Q37477768-60106F22-A013-4DBE-9509-2D0A9B887B11

Q37477768-6B5CF1A0-61FB-4ED3-8B9E-C89DB0821C55

Q37477768-94676C3B-24A8-4477-B8A4-8C3DDA475097

Q37477768-CAC600EB-2416-454E-A8CA-769BD502C65D

P2860

Q37477768-0661B515-4B1F-43FF-A8B2-DBEBAB3941CC

Q37477768-068150AD-A841-4431-BAEB-E4C1FD942A87

Q37477768-0D74D88A-D61F-4A0B-82F2-07274EC0FB2B

Q37477768-10EC1D79-BB1E-4DFF-A4F1-2611CB430504

Q37477768-1728AF74-6901-46DF-B204-FFC9434428CF

Q37477768-17FDB330-DAAC-4AE3-8F79-086887222EC8

Q37477768-1EB6973D-0F02-4877-90A5-1C39F78CBADF

Q37477768-245C1C47-B172-4222-9BAA-196AEC4FE54D

Q37477768-2B4D5286-1A9C-481B-98B1-53B5CBAB7F5A

Q37477768-337EC1CE-109D-4F6D-BE13-F8D5FDBA9C9D

P304

Q37477768-A9079194-B5A7-4D3B-ADE2-6CD6D81C8D37

P31

Q37477768-DDB028A5-1759-4E70-9B91-D4A02DE3EF26

P356

Q37477768-1C1B4E5D-B418-4673-BD62-74133BE7F8A9

P433

Q37477768-D6F34F67-AC8F-4BE2-9887-020E8D4DEE22

P478

Q37477768-BE04F891-3079-4FAE-B094-541F2CEC5CF9

P577

Q37477768-550B466B-4D22-4BD6-97B4-42B9355C0E93

P698

Q37477768-253D01C4-B5C0-43DE-95CA-B13C6A8D427E

P932

Q37477768-FF74FAF8-B1AE-49EC-B652-2D47F751965F

P356

P1433

Journal of the American Society of Nephrology

P1476

25-hydroxyvitamin D levels, race, and the progression of kidney disease.

@en

P2093

Brad Astor

http://www.w3.org/2001/XMLSchema#string

Erin D Michos

http://www.w3.org/2001/XMLSchema#string

Michal L Melamed

http://www.w3.org/2001/XMLSchema#string

Neil R Powe

http://www.w3.org/2001/XMLSchema#string

Paul Muntner

http://www.w3.org/2001/XMLSchema#string

Thomas H Hostetter

http://www.w3.org/2001/XMLSchema#string

P2860

25-hydroxyvitamin D levels and the risk of mortality in the general population

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women

A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Discrepancy in the epidemiology of nondiabetic chronic renal insufficiency and end-stage renal disease in black and white Americans: the third National Health and Nutrition Examination Survey and United States Renal Data System.

The prevalence of hypovitaminosis D among US adults: data from the NHANES III.

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.

Vitamin D and African Americans.

Skin-pigment regulation of vitamin-D biosynthesis in man.

P304

2631-2639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2009030283

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19875805

http://www.w3.org/2001/XMLSchema#string

P932

2794237

http://www.w3.org/2001/XMLSchema#string